GRP78 knockdown does not affect cytotoxicity of cisplatin in ovarian cancer cells

Standard

GRP78 knockdown does not affect cytotoxicity of cisplatin in ovarian cancer cells. / Kullmann, Maximilian; Kotz, Sandra; Hellwig, Malte; Kalayda, Ganna V; Metzger, Sabine; Jaehde, Ulrich.

In: INT J CLIN PHARM TH, Vol. 53, No. 12, 12.2015, p. 1038-40.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Kullmann, M, Kotz, S, Hellwig, M, Kalayda, GV, Metzger, S & Jaehde, U 2015, 'GRP78 knockdown does not affect cytotoxicity of cisplatin in ovarian cancer cells', INT J CLIN PHARM TH, vol. 53, no. 12, pp. 1038-40. https://doi.org/10.5414/CPXCES14EA02

APA

Kullmann, M., Kotz, S., Hellwig, M., Kalayda, G. V., Metzger, S., & Jaehde, U. (2015). GRP78 knockdown does not affect cytotoxicity of cisplatin in ovarian cancer cells. INT J CLIN PHARM TH, 53(12), 1038-40. https://doi.org/10.5414/CPXCES14EA02

Vancouver

Kullmann M, Kotz S, Hellwig M, Kalayda GV, Metzger S, Jaehde U. GRP78 knockdown does not affect cytotoxicity of cisplatin in ovarian cancer cells. INT J CLIN PHARM TH. 2015 Dec;53(12):1038-40. https://doi.org/10.5414/CPXCES14EA02

Bibtex

@article{bc1bd356f5a942b7b821a0aa10cf39b4,
title = "GRP78 knockdown does not affect cytotoxicity of cisplatin in ovarian cancer cells",
keywords = "Antineoplastic Agents/pharmacology, Cell Line, Tumor, Cisplatin/pharmacology, Drug Resistance, Neoplasm, Female, Heat-Shock Proteins/physiology, Humans, Ovarian Neoplasms/drug therapy",
author = "Maximilian Kullmann and Sandra Kotz and Malte Hellwig and Kalayda, {Ganna V} and Sabine Metzger and Ulrich Jaehde",
year = "2015",
month = dec,
doi = "10.5414/CPXCES14EA02",
language = "English",
volume = "53",
pages = "1038--40",
number = "12",

}

RIS

TY - JOUR

T1 - GRP78 knockdown does not affect cytotoxicity of cisplatin in ovarian cancer cells

AU - Kullmann, Maximilian

AU - Kotz, Sandra

AU - Hellwig, Malte

AU - Kalayda, Ganna V

AU - Metzger, Sabine

AU - Jaehde, Ulrich

PY - 2015/12

Y1 - 2015/12

KW - Antineoplastic Agents/pharmacology

KW - Cell Line, Tumor

KW - Cisplatin/pharmacology

KW - Drug Resistance, Neoplasm

KW - Female

KW - Heat-Shock Proteins/physiology

KW - Humans

KW - Ovarian Neoplasms/drug therapy

U2 - 10.5414/CPXCES14EA02

DO - 10.5414/CPXCES14EA02

M3 - SCORING: Journal article

C2 - 26521923

VL - 53

SP - 1038

EP - 1040

IS - 12

ER -